Scientists at Delix Therapeutics and UC Davis have engineered a modified LSD compound called JRT by altering just two atoms. This innovation preserves the therapeutic potential of LSD—boosting mood and cognition—while eliminating the hallucinogenic effects.
It’s part of a new wave of “non-hallucinogenic psychedelics” that could revolutionize treatment for depression, schizophrenia, and PTSD by enhancing brain plasticity without the trip.
#LSDResearch #NeuroScience #MentalHealthInnovation #NonHallucinogenic #Psychoplastogens #DepressionTreatment
It’s part of a new wave of “non-hallucinogenic psychedelics” that could revolutionize treatment for depression, schizophrenia, and PTSD by enhancing brain plasticity without the trip.
#LSDResearch #NeuroScience #MentalHealthInnovation #NonHallucinogenic #Psychoplastogens #DepressionTreatment
Scientists at Delix Therapeutics and UC Davis have engineered a modified LSD compound called JRT by altering just two atoms. This innovation preserves the therapeutic potential of LSD—boosting mood and cognition—while eliminating the hallucinogenic effects.
It’s part of a new wave of “non-hallucinogenic psychedelics” that could revolutionize treatment for depression, schizophrenia, and PTSD by enhancing brain plasticity without the trip.
#LSDResearch #NeuroScience #MentalHealthInnovation #NonHallucinogenic #Psychoplastogens #DepressionTreatment
0 Commentarii
0 Distribuiri
24K Views
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek
Arabic